Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maher

Showing results (1081-1090 of 1,158) with videos related to

Pageof 116
Sort By:
Nature Communications|September 27, 2023
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosisRichard J Hewitt, Franz Puttur, David C A Gaboriau, et al.
The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.
Respirology (Carlton, Vic.)|December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progressionCarmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
The European Respiratory Journal|April 18, 2020
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impactMartina Bonifazi, Nicola Sverzellati, Eva Negri, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2020
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary FibrosisRachele Invernizzi, Benjamin G Wu, Joseph Barnett, et al.
American Journal of Respiratory and Critical Care Medicine|April 13, 2022
Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary FibrosisDavid Zhang, Gundula Povysil, Philippe H Kobeissy, et al.
American Heart Journal|June 15, 2018
Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)Noel M Caplice, Mary C DeVoe, Janet Choi, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2023
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung DiseasesJoseph L Barnett, Toby M Maher, Jennifer K Quint, et al.
Cancer Research|May 12, 2017
ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup MedulloblastomasKatie B Grausam, Samuel D R Dooyema, Laure Bihannic, et al.
Pageof 116

Showing results (1081-1090 of 1,158) with videos related to

Sort By:
Pageof 116
Nature Communications|September 27, 2023
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosisRichard J Hewitt, Franz Puttur, David C A Gaboriau, et al.
The Lancet. Respiratory Medicine|January 7, 2021
Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trialKristin B Highland, Oliver Distler, Masataka Kuwana, et al.
Respirology (Carlton, Vic.)|December 18, 2020
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progressionCarmel J W Stock, Rachel K Hoyles, Cecile Daccord, et al.
The European Respiratory Journal|April 18, 2020
Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impactMartina Bonifazi, Nicola Sverzellati, Eva Negri, et al.
The Lancet. Respiratory Medicine|November 19, 2017
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort studyToby M Maher, Eunice Oballa, Juliet K Simpson, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2020
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary FibrosisRachele Invernizzi, Benjamin G Wu, Joseph Barnett, et al.
American Journal of Respiratory and Critical Care Medicine|April 13, 2022
Rare and Common Variants in <i>KIF15</i> Contribute to Genetic Risk of Idiopathic Pulmonary FibrosisDavid Zhang, Gundula Povysil, Philippe H Kobeissy, et al.
American Heart Journal|June 15, 2018
Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)Noel M Caplice, Mary C DeVoe, Janet Choi, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2023
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung DiseasesJoseph L Barnett, Toby M Maher, Jennifer K Quint, et al.
Cancer Research|May 12, 2017
ATOH1 Promotes Leptomeningeal Dissemination and Metastasis of Sonic Hedgehog Subgroup MedulloblastomasKatie B Grausam, Samuel D R Dooyema, Laure Bihannic, et al.
Pageof 116